14-64801382-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.666T>C​(p.Phe222Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00853 in 1,614,164 control chromosomes in the GnomAD database, including 313 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 74 hom., cov: 33)
Exomes 𝑓: 0.0074 ( 239 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.374

Publications

4 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 14-64801382-A-G is Benign according to our data. Variant chr14-64801382-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.374 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0599 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.666T>C p.Phe222Phe synonymous_variant Exon 7 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.666T>C p.Phe222Phe synonymous_variant Exon 7 of 36 NM_001355436.2 ENSP00000495909.1
SPTBENST00000389722.7 linkc.666T>C p.Phe222Phe synonymous_variant Exon 6 of 35 2 ENSP00000374372.3
SPTBENST00000389720.4 linkc.666T>C p.Phe222Phe synonymous_variant Exon 7 of 32 5 ENSP00000374370.4

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2925
AN:
152230
Hom.:
74
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0398
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.0324
Gnomad SAS
AF:
0.0240
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.0224
GnomAD2 exomes
AF:
0.0185
AC:
4653
AN:
251442
AF XY:
0.0165
show subpopulations
Gnomad AFR exome
AF:
0.0436
Gnomad AMR exome
AF:
0.0625
Gnomad ASJ exome
AF:
0.0258
Gnomad EAS exome
AF:
0.0234
Gnomad FIN exome
AF:
0.000832
Gnomad NFE exome
AF:
0.00178
Gnomad OTH exome
AF:
0.0135
GnomAD4 exome
AF:
0.00742
AC:
10843
AN:
1461816
Hom.:
239
Cov.:
32
AF XY:
0.00758
AC XY:
5511
AN XY:
727204
show subpopulations
African (AFR)
AF:
0.0451
AC:
1511
AN:
33472
American (AMR)
AF:
0.0619
AC:
2767
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0270
AC:
705
AN:
26134
East Asian (EAS)
AF:
0.0349
AC:
1387
AN:
39696
South Asian (SAS)
AF:
0.0259
AC:
2237
AN:
86252
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53400
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
0.00137
AC:
1528
AN:
1111978
Other (OTH)
AF:
0.0105
AC:
634
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
695
1390
2085
2780
3475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0192
AC:
2930
AN:
152348
Hom.:
74
Cov.:
33
AF XY:
0.0192
AC XY:
1431
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0429
AC:
1785
AN:
41574
American (AMR)
AF:
0.0400
AC:
612
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
73
AN:
3472
East Asian (EAS)
AF:
0.0326
AC:
169
AN:
5180
South Asian (SAS)
AF:
0.0236
AC:
114
AN:
4832
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00179
AC:
122
AN:
68034
Other (OTH)
AF:
0.0222
AC:
47
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
152
305
457
610
762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0104
Hom.:
70
Bravo
AF:
0.0253
Asia WGS
AF:
0.0360
AC:
124
AN:
3478
EpiCase
AF:
0.00185
EpiControl
AF:
0.00213

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 14, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.4
DANN
Benign
0.74
PhyloP100
0.37
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17102119; hg19: chr14-65268100; API